CLGN CollPlant Biotechnologies Earnings per share growth rate in current year
Stable delivery of plant-based biomaterials supports regenerative medicine, yet CollPlant Biotechnologies (CLGN) faces a costly period and regulatory barriers. Future growth depends on FDA approval and the success of alliances with pharmaceutical behemoths. The annual earnings per share growth indicator reflects the business recovery trend, where 0.00 characterizes this valuation parameter, confirming the company's fundamental recovery.
Analytical breakdowns and data insights for company collplant.com (CLGN)
- price and consensus price forecast:
- market capitalization data:
- balance sheet equity data:
- debt and liquidity details:
Aggregate Debt to Equity CollPlant Biotechnologies|CLGN - Long-Term Debt to Equity|Short-Term Debt to Equity CollPlant Biotechnologies Ltd.|CLGN - Company Aggregate Debts|Debts to Book Capitalization CLGN|CLGN - Company Long-Term Debt|Company Short-Term Indebtedness CollPlant Biotechnologies|Intermediate Liquidity Ratio collplant.com
- earnings and valuation multiples information:
CLGN - Net Income|Expected Net Income CollPlant Biotechnologies|CLGN - P/E Multiple|Future Price to Earnings CollPlant Biotechnologies Ltd.|CLGN - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio CLGN|CLGN - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months CollPlant Biotechnologies|CLGN - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months collplant.com|CLGN - Earnings growth in current year|Expected net earnings per share growth next year CollPlant Biotechnologies
Fundamental valuation:CollPlant Biotechnologies
Investors require an objective basis to evaluate the effectiveness of capital management. The current model of CollPlant Biotechnologies (CLGN) relies on cash inflows from the licensing of 3D bioprinting in aesthetics. The EPS growth rate compared to last year measures the percentage change in net income per share, reflecting the actual pace of business scaling. This positive trend confirms the conversion of technological agreements into actual revenue, serving as a key indicator of the asset's financial stability.
Main competitors
Net earnings per share growth this year HCA Healthcare|Earnings per share growth in current year Tenet|Earnings per share growth rate in current year Fresenius Medical FMS|Earnings per share growth in current year Solventum Corporation (SOLV)|Earnings per share growth in current year EHC (encompasshealth.com)|Earnings per share growth in current year Universal Health Services, Inc. UHS|DaVita HealthCare Partners - Earnings per share growth in current year|RDNT - Earnings per share growth in current year|Earnings per share trend in current year OPCH|Surgery Partners, Inc. (SGRY) - Earnings per share growth in current year|PINC (premierinc.com) - Earnings per share growth in current year|EYE (National Vision) - Earnings growth in current year|Earnings growth in current year Progyny Inc|Earnings per share growth in current year Ardent Health Partners Inc (ARDT)|Select Medical Inc. - Earnings per share growth this year|Astrana Health, Inc. - Net earnings per share growth this year|Net earnings per one share growth for the current year MD (mednax.com)|USPH: Net earnings per share growth this year|Earnings per share increase in current year PNTG (Pennant Group)|ORGO: Earnings growth in current year|NUTX (Nutex Health Hospitals) - Earnings per share growth in current year|AUNA (Auna SA) - Earnings growth in current year|SBC Medical Group Holdings Inc (SBC) - Expected net earnings per share growth this year|Earnings per share growth in current year Evolus (EOLS)|CYH - Earnings per share growth rate in current year|BeautyHealth - Net earnings per share growth this year|Net earnings per one share growth for the current year MDWD (MediWound Ltd)|biote Corp. - Earnings growth in current year|Earnings per share growth rate in current year thejoint.com|DCGO: Earnings growth in current year|Net earnings per share growth this year P3 Health Partners|GANX (Gain Therapeutics) - Earnings growth in current year|EUDA: Earnings per share increase in current year|Earnings per share growth in current year Basel Medical Group (BMGL)|cuprina.com.sg - Earnings per share growth this year|Earnings per share growth in current year Concord Medical CCM|American Shared Hospital Services Inc (AMS) - Earnings per share growth rate in current year|MRM - Earnings per share growth in current year|ALBT: Earnings per share growth in current year|DIH Holding US, Inc. (DHAI) - Earnings per share growth in current year|Earnings per share growth rate in current year carmellcosmetics.com (XAGE)|NIVF (NewGenIvf) - Earnings growth in current year|ATIP - Net earnings per share change in current year|Earnings growth in current year CMAX|Expected net earnings per share growth this year Kindly Health|Earnings growth in current year MODV (ModivCare Inc.)|novointegrated.com (NVOS) - Earnings per share growth rate in current year|SSY - Earnings per share growth in current year|Expected net earnings per share growth this year IMAC Holdings Inc BACK
